
Patients, Companies and Platforms Oppose Tightening of the CanG
Parts of the German federal government are dissatisfied with the current interpretation of the Cannabis Act (CanG), introduced by the

Parts of the German federal government are dissatisfied with the current interpretation of the Cannabis Act (CanG), introduced by the

Over the past few years, telemedicine has reshaped how patients access medical cannabis, launching a wave of digital clinics across

A comprehensive cross-section of the world’s most influential policymakers and global regulatory officials are set to meet with a group

A month out from Germany’s federal election, alarm bells are ringing for the booming cannabis market.

Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has published the medical cannabis import figures for Q3, showing that

As reported by Cannabis Health A new survey following the landmark law change in Germany has revealed that the majority

Last month, Germany’s Federal Joint Committee (G-BA) proposed significant changes to the medical cannabis prescription process, opening the door for

Award-winning Frankfurt, Germany-based medical cannabis company Bloomwell Group GmbH (“Bloomwell Group”) released a report today on the state of Germany’s private, self-funded, medical cannabis

2023 was a year in which Germany, the European Union’s most populous country which has (in various forms) promised to

Germany’s Cannabis Act (CanG) took another important step forward this week after its first parliamentary debate was held in the
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.